Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study

Last 30 days: 60 accesses
Last 365 days: 814 accesses
All time: 5560 accesses

Serge D Steinfeld^*, Laure Tant, Gerd R Burmester, Nick KW Teoh, William A Wegener, David M Goldenberg and Olivier Pradier